Related Articles
Astragaloside Ⅳ reduces the expression level of P‑glycoprotein in multidrug‑resistant human hepatic cancer cell lines
Astragaloside IV regulates NF‑κB‑mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF‑BB‑induced activation
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis
Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6